Int J Med Sci 2020; 17(14):2095-2103. doi:10.7150/ijms.45842 This issue

Research Paper

Tert-butylhydroquinone mitigates Carbon Tetrachloride induced Hepatic Injury in mice

Ruidong Li, Peng Zhang, Chengguo Li, Wenchang Yang, Yuping Yin, Kaixiong Tao

Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

This is an open access article distributed under the terms of the Creative Commons Attribution License ( See for full terms and conditions.
Li R, Zhang P, Li C, Yang W, Yin Y, Tao K. Tert-butylhydroquinone mitigates Carbon Tetrachloride induced Hepatic Injury in mice. Int J Med Sci 2020; 17(14):2095-2103. doi:10.7150/ijms.45842. Available from

File import instruction


Tert-butylhydroquinone (tBHQ) is an antioxidant compound that exhibits cytoprotective effect in many tissues under pathological condition. However, its role in carbon tetrachloride (CCL4) induced liver injury is still unclear. Here we established a carbon tetrachloride induced hepatic injury model in mice to determine whether tBHQ can mitigate CCL4 induced liver damage. In our study, we found tBHQ exhibited protective effects in CCL4 treated mice model. TBHQ markedly improved hepatic function and decreased hepatic histopathological damage in vivo. In addition, tBHQ reduced levels of pro-inflammatory cytokines in mice model. Moreover, tBHQ mitigated apoptosis of hepatocytes, oxidative stress and lipid peroxidation in vivo and in vitro. We also found the possible mechanism of protective effects of tBHQ was associated with activation of Nrf2/ heme oxygenase-1 (HO-1) pathway. In conclusion, our study revealed tBHQ can be a potential therapeutic drug in treatment of acute hepatic injury.

Keywords: Tert-butylhydroquinone, liver injury, Nrf2, oxidative stress